Severe pediatric cardiac decompensation has a mortality risk of 50-65% and is the leading cause of death in children. Heart transplantation is the current standard of care for end-stage pediatric ...

For patients with heart failure, blood pumps can be lifesaving. But the very forces that sustain circulation can also harm it, damaging red blood cells through hemolysis and compromising the body's ...

CircuLite, a Saddle Brook, New Jersey medical device company, has raised $30 million in an oversubscribed series D round of financing for the development of what it describes as the world’s smallest ...

Physicians at Emory University Hospital performed the first-ever surgical implantation in the United States of a brand-new type of heart pump designed to help save patients with heart failure, using a ...

A small, implantable cardiac pump that could help children await heart transplants at home, not in the hospital, has performed well in the first stage of human testing. The pump, a new type of ...

The FDA has issued an alert about a potentially high-risk issue involving Abiomed’s Automated Impella Controller, which is used with the company’s blood pump systems. Abiomed, now part of Johnson & ...